Notably, other than RPN2, which has been shown to promote radioresistance via upregulating STAT3 signaling in gliomas (Li et al., 2020), none of the genes in ESURATAG-GS have been studied in the context of glioma, highlighting the novelty of our findings. This evidence concerns the gene STAT3 and central nervous system cancer.